A two day course that will give you an understanding of antibody research. From bioinformatics to human drug trials including the legal challenges involved.
UCL, Bloomsbury Campus London
2nd and 3rd July 2020 Cancelled
Course leader: Professor Andrew Martin, Division of Biosciences UCL
Co-leader: Professor Kerry Chester, UCL Cancer Institute
It is estimated that antibodies now represent around one third of all drugs in development. This course consists of lectures and workshops that will teach you how to search for antibodies using powerful bioinformatic software, how to interpret the findings, and how the results are used by Professor Chester to design therapeutics at the UCL Cancer Institute and their use in human drug trials.
Suitable for all scientific disciplines
approved by RSB for 48 credit points